Long Ruqian, CEO of Xiaoai Technology
On October 31, the ATA Forum’s U.S.-China Dialogue Session was held in Beijing. Long Ruqian, CEO of Chongqing Xiaoai Technology Co., Ltd. and initiator of the hit JD.com crowdfunding project aiShoes, delivered a compelling keynote address, in which he presented six thought-provoking perspectives on the design of internet-based medical and health products.
The first category: patients who are not actually patients,Pregnant women, infants, and children;SecondPatients Who Cannot Be Cured, for instance, in Parkinson’s disease patients, progression from Stage I to Stage V ultimately leads to death. Since Parkinson’s disease is virtually incurable, the only recourse is to improve the patient’s quality of life;There Is Another Category of Patients Who Believe Themselves to Be Ill, for instance, beauty-conscious women apply makeup and maintain their figures daily, while some others undergo plastic surgery to transform themselves.

Our products are essentials in the daily life and work scenarios of our target users; we do not conceive or fabricate products without basis. Currently, our product lineup is primarily designed for women: we provide cosmetics when they are not pregnant, support them throughout their pregnancy, and offer services for their children after childbirth. Our business model predominantly integrates smart hardware with cloud computing or data services via a mobile app, often incorporating professional medical services provided by doctors.
aiShoes smart maternity shoes launched on JD.com’s crowdfunding platform in October, surpassing RMB 1 million within the first six hours. The campaign has now raised nearly RMB 3 million and is still ongoing. During the crowdfunding period, we gathered extensive feedback from potential users regarding product adjustments. Over the approximately 45-day campaign, our product underwent six iterations, covering everything from the shoes themselves to the companion mobile app and hardware components, with each segment iterating two to three times.
We partner with the leading brand in its respective industry, integrating its supply chain with ours to rapidly bring products to market.
Next year, we will have 1,000 Xiao Ai Smart Experience Stores across China. None of these stores will carry inventory. Each store is equipped with a 3D foot scanner that can model and analyze your feet in just 10 seconds. Once you place an order, you can simply go home and wait for delivery. This model truly achieves personalized customization and on-demand production, addressing a severe issue in the traditional supply chain: inventory. A pair of shoes that costs 80 yuan to produce ends up selling for 480 yuan to consumers, because 400 yuan of that price is attributed to inventory costs.
Our aiFace Smart CC Cream partners with over 2,000 distributors across China, making it a product line with tens of millions in revenue. Moreover, our supply chain is fully established, and the “zero-inventory” model can instantly onboard distributors with potential sales reaching RMB 5 million. Priced at RMB 365, this product offers a cashback of RMB 1 per day for twice-daily use, fully reimbursing the purchase price within a year. We believe that following the success of our aiFace Smart Maternity Shoes, the aiFace Smart CC Cream will drive the next wave of sales growth.
Related Reports:
JD Crowdfunding Star Project aiShoes: The Product Logic Behind a Pair of Smart Maternity Shoes